Kelly Stevenson, PA
Physician Assistant · Kearney, NENPI 1154634244
Payments from drug & device makers
Across 116 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$591
- Abbott$390
- AbbVie$334
- AstraZeneca$245
- Saluda Medical Americas, Inc.$213
- SPR Therapeutics, Inc$103
- plus $703 from 19 others
What the payments were for
- Food & beverage$2,578100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 16 | $591 |
| Abbott | 18 | $390 |
| AbbVie | 28 | $334 |
| AstraZeneca | 5 | $245 |
| Saluda Medical Americas, Inc. | 11 | $213 |
| SPR Therapeutics, Inc | 3 | $103 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $88 |
| Astellas Pharma US Inc | 2 | $60 |
| Lundbeck LLC | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Novo Nordisk | 3 | $56 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Pfizer | 2 | $39 |
| Vertos Medical, Inc. | 1 | $35 |
| Bayer | 2 | $33 |
| Forte Bio-pharma LLC | 2 | $32 |
| Kerecis Limited | 1 | $28 |
| Averitas Pharma Inc. | 1 | $23 |
| Soleno Therapeutics, Inc. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Si-bone, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,578 in reported general payments places this provider in the 85th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 393 | $12,444 |
| Emgality PenGalcanezumab-Gnlm | 14 | $10,216 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 146 | $4,349 |
| Gabapentin | 224 | $3,289 |
| Tizanidine Hcl | 147 | $2,258 |
| Lidocaine | 20 | $2,236 |
| Tramadol Hcl | 140 | $2,027 |
| Pregabalin | 87 | $1,816 |
| Cyclobenzaprine Hcl | 114 | $1,398 |
| Morphine Sulfate ErMorphine Sulfate | 52 | $1,187 |
| Oxycodone Hcl | 57 | $1,056 |
| Baclofen | 51 | $640 |
| Ropinirole Hcl | 30 | $591 |
| Methocarbamol | 17 | $443 |
| Celecoxib | 27 | $267 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Kearney
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Ronda FoleyElkhorn$64K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Joel JasaGrand Island$18K
- Christopher BeasleyOmaha$15K
- Laura TvrdyLincoln$13K
- Courtney MaresLincoln$13K
- Corrine GiggeeOmaha$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.